Updates
Press Release
Lupin LimitedLUPIN · Filed with the exchange
Lupin received U.S.
FDA final approval for its generic Pitolisant Tablets (4.45 mg & 17.8 mg), bioequivalent to Wakix®. This expands the company's product portfolio for the US market.
No comments yet. Be the first.